The Research On Identification And Regulation Of Financial Risk Of ChemChina M&A Syngenta

At present,mergers and acquisitions(M&A)and integration of global industries are the general trend,and Chinese enterprises also participate in international competition through cross-border M&A.With the implementation of the "going global" strategy and the in-depth guidance of "one belt and one road",the cross-border M&A market in China has been developing vigorously.The volume and number of transactions have shown explosive growth,and Chinese enterprises have become the main force of cross-border M&A in the world.However,cross-border M&A in China faces many financial risks and high failure rate due to the fact that Chinese cross-border M&A is still in its infancy and lacks rich guiding experience.Controlling financial risks can greatly reduce the risks in cross-border M&A.Therefore,it is particularly important to identify and pay attention to the possible financial risks in the prevention of cross-border M&A,which to a large extent determines the success of cross-border M&A.In order to avoid and reduce financial risks effectively and improve the success rate of M&A,this paper chooses the classic case of ChemChina M&A of Switzerland Syngenta as the object of analysis based on the related concepts and theoretical basis of cross-border M&A.Through the specific reduction and analysis of the case,this paper analyzes the identification and regulation of financial risks in the process of M&A by combining with the analysis of financial data and indicators.The result shows that,there are financial risks in the process of M&A,such as target selection,enterprise value evaluation,financing,payment,debt repayment and integration.Combining with the countermeasure of ChemChina,this paper puts forward some effective measures to prevent the financial risk in cross-border M&A.This not only has practical guiding significance for cross-border M&A of ChemChina and other enterprises,but also enlightens the M&A activities of China's enterprises.